ERBB2 and neoplasm: In addition, Christmas et al. showed that targeting MDSC migration using HDAC inhibitor in combination with anti-PD-1, anti-CTLA-4, or both, significantly reduces MDSC infiltration and tumor growth in HER2/neu transgenic mice [93].